HYPD Insider Trading
Insider Ownership Percentage: 10.86%
Insider Buying (Last 12 Months): $611,466.94
Insider Selling (Last 12 Months): $0.00
Hyperion DeFi Share Price & Price History
Current Price: $2.99
Price Change: +0.30 (1.20%)
As of 02/24/2026 05:00 PM ET
Hyperion DeFi Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/31/2025 | David R Knox | CFO | Buy | 27,950 | $3.59 | $100,340.50 | 327,950 |  |
| 12/29/2025 | Ellen R Strahlman | Director | Buy | 12,112 | $3.60 | $43,603.20 | 91,161 | |
| 12/29/2025 | Ellen R Strahlman | Director | Buy | 11,856 | $3.61 | $42,800.16 | 34,869 | |
| 12/26/2025 | Ellen R Strahlman | Director | Buy | 3,601 | $3.86 | $13,899.86 | 79,049 | |
| 12/26/2025 | Ellen R Strahlman | Director | Buy | 3,311 | $3.86 | $12,780.46 | 23,013 | |
| 12/18/2025 | Ellen R Strahlman | Director | Buy | 18,742 | $3.14 | $58,849.88 | 75,448 | |
| 12/18/2025 | Ellen R Strahlman | Director | Buy | 19,702 | $3.14 | $61,864.28 | 95,150 | |
| 12/17/2025 | Happy David Walters | Director | Buy | 61,930 | $3.02 | $187,028.60 | 111,930 | |
| 12/17/2025 | Michael S Geltzeiler | Director | Buy | 30,000 | $3.01 | $90,300.00 | 88,015 | |
| 8/28/2024 | Michael M. Rowe | CEO | Buy | 338 | $41.60 | $14,060.80 | 1,374 | |
| 8/26/2024 | Michael M. Rowe | CEO | Buy | 625 | $45.60 | $28,500.00 | 1,036 | |
| 7/2/2024 | Stuart M Grant | Major Shareholder | Buy | 18,939 | $52.80 | $999,979.20 | 136,426 | |
| 3/28/2024 | Stuart M Grant | Major Shareholder | Buy | 1,250 | $78.40 | $98,000.00 | 67,883 | |
| 3/19/2024 | Stuart M Grant | Major Shareholder | Buy | 625 | $98.40 | $61,500.00 | 66,633 | |
| 3/8/2024 | Stuart M Grant | Major Shareholder | Buy | 133 | $126.40 | $16,811.20 | 66,008 | |
| 12/4/2023 | Michael M. Rowe | CEO | Buy | 61 | $108.80 | $6,636.80 | 411 | |
| 9/29/2023 | Ellen R Strahlman | Director | Buy | 60 | $134.40 | $8,064.00 | 938 | |
| 9/19/2023 | Michael M. Rowe | CEO | Buy | 17 | $132.80 | $2,257.60 | 350 | |
| 9/15/2023 | Michael M. Rowe | CEO | Buy | 14 | $140.00 | $1,960.00 | 332 | |
| 8/16/2023 | Stuart M Grant | Major Shareholder | Buy | 562 | $152.80 | $85,873.60 | 65,499 | |
| 5/31/2023 | John P Gandolfo | CFO | Buy | 25 | $223.20 | $5,580.00 | 100 | |
| 5/26/2023 | Bren Kern | COO | Buy | 31 | $218.40 | $6,770.40 | 31 | |
| 5/26/2023 | Charles E. Mather, IV | Director | Buy | 37 | $199.20 | $7,370.40 | 969 | |
| 5/25/2023 | Stuart M Grant | Major Shareholder | Buy | 1,103 | $212.00 | $233,836.00 | 64,937 | |
| 5/23/2023 | Ellen R Strahlman | Director | Buy | 125 | $248.00 | $31,000.00 | 663 | |
| 5/1/2023 | Tsontcho Ianchulev | Director | Sell | 1,125 | $440.00 | $495,000.00 | 4,140 | |
| 4/27/2023 | Tsontcho Ianchulev | Director | Sell | 750 | $400.00 | $300,000.00 | 5,265 | |
| 4/14/2023 | Tsontcho Ianchulev | Director | Sell | 500 | $360.00 | $180,000.00 | 6,015 | |
| 4/11/2023 | Tsontcho Ianchulev | Director | Sell | 500 | $320.00 | $160,000.00 | 6,515 | |
| 3/31/2023 | Tsontcho Ianchulev | Director | Sell | 500 | $280.00 | $140,000.00 | 7,015 | |
Hyperion DeFi Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/17/2026 | Price T Rowe Associates Inc. MD | 20,500 | $73K | 0.0% | N/A | 0.251% |  |
| 2/13/2026 | State Street Corp | 25,857 | $92K | 0.0% | N/A | 0.316% | |
| 2/12/2026 | Jane Street Group LLC | 138,421 | $0.49M | 0.0% | N/A | 1.694% | |
| 2/12/2026 | Renaissance Technologies LLC | 186,100 | $0.66M | 0.0% | N/A | 2.277% | |
| 2/11/2026 | Focus Partners Advisor Solutions LLC | 62,183 | $0.22M | 0.0% | N/A | 0.761% | |
| 2/9/2026 | Geode Capital Management LLC | 60,194 | $0.21M | 0.0% | N/A | 0.736% | |
| 2/6/2026 | Investment House LLC | 46,675 | $0.17M | 0.0% | N/A | 0.571% | |
| 1/29/2026 | Sanctuary Advisors LLC | 10,800 | $38K | 0.0% | N/A | 0.132% | |
| 1/26/2026 | Nations Financial Group Inc. IA ADV | 11,125 | $40K | 0.0% | N/A | 0.136% | |
| 1/16/2026 | Formidable Asset Management LLC | 23,380 | $83K | 0.0% | N/A | 0.286% | |
| 5/14/2025 | Lasry Marc | 30,618 | $34K | 0.2% | -98.8% | 1.082% | |
| 5/12/2025 | Virtu Financial LLC | 23,065 | $25K | 0.0% | N/A | 0.815% | |
| 2/12/2025 | Geode Capital Management LLC | 577,393 | $84K | 0.0% | +3.5% | 41.539% | |
| 11/16/2024 | Geode Capital Management LLC | 557,994 | $0.29M | 0.0% | +36.6% | 0.871% | |
| 11/5/2024 | Nations Financial Group Inc. IA ADV | 90,900 | $47K | 0.0% | +78.6% | 0.142% | |
| 10/23/2024 | Financial Management Network Inc. | 81,250 | $39K | 0.0% | N/A | 0.151% | |
| 9/16/2024 | Point72 Asia Singapore Pte. Ltd. | 43,784 | $26K | 0.0% | N/A | 0.081% | |
| 8/16/2024 | SkyView Investment Advisors LLC | 146,071 | $87K | 0.0% | N/A | 0.271% | |
| 8/15/2024 | Armistice Capital LLC | 6,060,606 | $3.60M | 0.0% | N/A | 11.250% | |
| 8/15/2024 | Point72 Asia Singapore Pte. Ltd. | 43,784 | $26K | 0.0% | N/A | 0.081% | |
| 8/8/2024 | Ground Swell Capital LLC | 45,258 | $27K | 0.0% | N/A | 0.084% | |
| 7/29/2024 | Nations Financial Group Inc. IA ADV | 50,900 | $30K | 0.0% | +24.4% | 0.094% | |
| 5/10/2024 | Vanguard Group Inc. | 1,790,501 | $1.77M | 0.0% | +25.2% | 3.514% | |
| 5/1/2024 | BNP Paribas Financial Markets | 219,610 | $0.22M | 0.0% | +1,444.4% | 0.431% | |
| 4/22/2024 | PFG Investments LLC | 70,000 | $69K | 0.0% | N/A | 0.148% | |
| 3/14/2024 | Leo Wealth LLC | 16,112 | $34K | 0.0% | N/A | 0.037% | |
| 2/13/2024 | Armistice Capital LLC | 4,378,000 | $9.11M | 0.1% | +41.8% | 9.923% | |
| 2/9/2024 | Nations Financial Group Inc. IA ADV | 40,500 | $84K | 0.0% | N/A | 0.092% | |
| 11/15/2023 | Armistice Capital LLC | 3,087,021 | $5.12M | 0.1% | N/A | 8.079% | |
| 10/24/2023 | Financial Management Network Inc. | 81,250 | $0.13M | 0.0% | N/A | 0.213% | |
| 8/10/2023 | Meitav Investment House Ltd. | 10,350 | $1.10M | 0.0% | N/A | 0.027% | |
| 8/4/2023 | American International Group Inc. | 13,389 | $32K | 0.0% | N/A | 0.035% | |
| 8/2/2023 | Oak Family Advisors LLC | 61,146 | $0.15M | 0.1% | +36.9% | 0.161% | |
| 7/24/2023 | Meitav Investment House Ltd. | 10,350 | $1.10M | 0.0% | N/A | 0.027% | |
| 7/18/2023 | Denali Advisors LLC | 31,500 | $75K | 0.0% | N/A | 0.083% | |
| 5/30/2023 | BKA Wealth Consulting Inc. | 80,000 | $0.30M | 0.1% | N/A | 0.211% | |
| 5/2/2023 | Leo Brokerage LLC | 16,112 | $57K | 0.0% | N/A | 0.042% | |
| 5/1/2023 | Virtu Financial LLC | 20,741 | $73K | 0.0% | +27.8% | 0.055% | |
| 4/21/2023 | BKA Wealth Consulting Inc. | 80,000 | $0.30M | 0.1% | N/A | 0.211% | |
| 3/24/2023 | Palisade Capital Management LP | 315,029 | $0.51M | 0.0% | N/A | 0.872% | |
| 2/14/2023 | Palisade Capital Management LLC NJ | 315,029 | $0.51M | 0.0% | N/A | 0.872% | |
| 1/27/2023 | Oak Family Advisors LLC | 46,073 | $75K | 0.0% | -22.2% | 0.128% | |
| 11/4/2022 | Vontobel Holding Ltd. | 16,840 | $33K | 0.0% | N/A | 0.049% | |
| 4/26/2022 | AMH Equity Ltd | 12,152 | $37K | 0.0% | -87.8% | 0.038% | |
| 4/13/2022 | Hexagon Capital Partners LLC | 10,000 | $30K | 0.0% | N/A | 0.032% | |
| 2/9/2022 | Saltoro Capital LP | 27,773 | $0.11M | 0.0% | -84.0% | 0.098% | |
| 1/24/2022 | AMH Equity Ltd | 100,000 | $0.40M | 0.6% | N/A | 0.352% | |
| 11/16/2021 | Two Sigma Advisers LP | 88,800 | $0.44M | 0.0% | -52.1% | 0.342% | |
| 11/16/2021 | Two Sigma Investments LP | 80,847 | $0.40M | 0.0% | -63.5% | 0.312% | |
| 11/12/2021 | Renaissance Technologies LLC | 197,800 | $0.97M | 0.0% | +32.6% | 0.762% | |
| 11/9/2021 | BlackRock Inc. | 55,836 | $0.27M | 0.0% | -7.3% | 0.215% | |
Data available starting January 2016
Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.
Read More on Hyperion DeFi
Volume
264,493 shs
Average Volume
386,491 shs
Market Capitalization
$24.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.69
Who are the company insiders with the largest holdings of Hyperion DeFi?
Who are the major institutional investors of Hyperion DeFi?
Which institutional investors are buying Hyperion DeFi stock?
During the previous quarter, HYPD stock was acquired by institutional investors including:
- Renaissance Technologies LLC
- Jane Street Group LLC
- Focus Partners Advisor Solutions LLC
- Geode Capital Management LLC
- Investment House LLC
- State Street Corp
- Formidable Asset Management LLC
- Price T Rowe Associates Inc. MD
During the previous year, these company insiders have bought Hyperion DeFi stock:
- David R Knox (CFO)
- Stuart M Grant (Major Shareholder)
- Happy David Walters (Director)
- Ellen R Strahlman (Director)
- Michael S Geltzeiler (Director)
- Michael M Rowe (CEO)
Learn More investors buying Hyperion DeFi stock.
